You are currently viewing a new version of our website. To view the old version click .

Cancers, Volume 12, Issue 11

November 2020 - 412 articles

Cover Story: Acute myeloid leukemia (AML) is a complex disease characterized by clonal expansion of undifferentiated myeloid precursors and failed hematopoiesis. Traditionally, chemotherapy has been the mainstay of treatment, consisting of either high-dose cytarabine-containing regimens or lower-intensity treatments such as hypomethylating agents. Recent advances in genetic sequencing, understanding of genomic aberrations, and pathogenesis of AML have transformed the range of drug targets available. Genetic-targeted therapies (FLT3-inhibitors and IDH1/2-inhibitors) have already been approved, while others are under investigation. Approvals of non-genetically targeted therapies (liposomal chemotherapy, venetoclax, and glasdegib) and immunotherapies (gemtuzumab ozogamicin) have also added to the armamentarium. AML drug development remains an innovative frontier with many new agents under investigation. View this paper.
  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (412)

  • Article
  • Open Access
18 Citations
3,881 Views
14 Pages

Total Pelvic Exenteration, Cytoreductive Surgery, and Hyperthermic Intraperitoneal Chemotherapy for Rectal Cancer with Associate Peritoneal Metastases: Surgical Strategies to Optimize Safety

  • Jean-Jacques Tuech,
  • Jean Pinson,
  • François-Xavier Nouhaud,
  • Gregory Wood,
  • Thomas Clavier,
  • Jean-Christophe Sabourin,
  • Frederic Di Fiore,
  • Matthieu Monge,
  • Eloïse Papet and
  • Julien Coget

23 November 2020

Background: Cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) is a curative treatment option for patients with peritoneal carcinomatosis. Total pelvic exenteration (TPE) is an established treatment option for locally...

  • Article
  • Open Access
20 Citations
4,961 Views
12 Pages

Breast Cancer Mortality among Women with a BRCA1 or BRCA2 Mutation in a Magnetic Resonance Imaging Plus Mammography Screening Program

  • Ellen Warner,
  • Siqi Zhu,
  • Donald B. Plewes,
  • Kimberley Hill,
  • Elizabeth A. Ramsay,
  • Petrina A. Causer,
  • Jean Seely,
  • Roberta A. Jong,
  • Pamela Lenkov and
  • Christine Elser
  • + 5 authors

23 November 2020

Annual breast magnetic resonance imaging (MRI) plus mammography is the standard of care for screening women with inherited BRCA1/2 mutations. However, long-term breast cancer-related mortality with screening is unknown. Between 1997 and June 2011, 48...

  • Article
  • Open Access
27 Citations
3,657 Views
15 Pages

23 November 2020

Although rare, immune checkpoint inhibitor (ICI)-related myocarditis can be life-threatening, even fatal. In view of increased ICI prescription, identification of clinical risk factors for ICI-related myocarditis is of primary importance. This study...

  • Review
  • Open Access
14 Citations
3,276 Views
24 Pages

23 November 2020

The genetic and molecular underpinnings of metastatic colorectal cancer have been studied for decades, and the applicability of these findings in clinical decision making continues to evolve. Advancements in translating molecular studies have provide...

  • Article
  • Open Access
11 Citations
4,543 Views
20 Pages

A Combined Systemic Strategy for Overcoming Cisplatin Resistance in Head and Neck Cancer: From Target Identification to Drug Discovery

  • Yin-Ju Chen,
  • Guo-Rung You,
  • Meng-Yu Lai,
  • Long-Sheng Lu,
  • Chang-Yu Chen,
  • Lai-Lei Ting,
  • Hsin-Lun Lee,
  • Yuzuka Kanno,
  • Jeng-Fong Chiou and
  • Ann-Joy Cheng

23 November 2020

Cisplatin is the first-line chemotherapy agent for head and neck cancer (HNC), but its therapeutic effects are hampered by its resistance. In this study, we employed systemic strategies to overcome cisplatin resistance (CR) in HNC. CR cells derived f...

  • Review
  • Open Access
13 Citations
3,509 Views
13 Pages

Pigment Epithelium-Derived Factor and Sex Hormone-Responsive Cancers

  • Naomi Brook,
  • Emily Brook,
  • Crispin R. Dass,
  • Arlene Chan and
  • Arun Dharmarajan

23 November 2020

Oestrogens and androgens play important roles in normal and cancerous tissue and have been shown to negatively regulate pigment epithelium-derived factor (PEDF) expression in sex hormone-responsive tumours. PEDF suppresses tumour growth and its downr...

  • Article
  • Open Access
14 Citations
5,782 Views
26 Pages

23 November 2020

In this study, we differentiated murine bone marrow-derived macrophages (BMDMs) into M0, M1, and M2 in the presence or absence of calcitriol. Real-time PCR analysis of gene expression, FACS analysis of surface markers, and chemokine/cytokine producti...

  • Article
  • Open Access
11 Citations
3,140 Views
20 Pages

Evidences of a Direct Relationship between Cellular Fuel Supply and Ciliogenesis Regulated by Hypoxic VDAC1-ΔC

  • Monique Meyenberg Cunha-de Padua,
  • Lucilla Fabbri,
  • Maeva Dufies,
  • Sandra Lacas-Gervais,
  • Julie Contenti,
  • Charles Voyton,
  • Sofia Fazio,
  • Marie Irondelle,
  • Baharia Mograbi and
  • Matthieu Rouleau
  • + 8 authors

23 November 2020

Metabolic flexibility is the ability of a cell to adapt its metabolism to changes in its surrounding environment. Such adaptability, combined with apoptosis resistance provides cancer cells with a survival advantage. Mitochondrial voltage-dependent a...

  • Article
  • Open Access
14 Citations
3,262 Views
11 Pages

Circulating Tumour DNA in Advanced Melanoma Patients Ceasing PD1 Inhibition in the Absence of Disease Progression

  • Lydia Warburton,
  • Leslie Calapre,
  • Michelle R. Pereira,
  • Anna Reid,
  • Cleo Robinson,
  • Benhur Amanuel,
  • Mel Ziman,
  • Michael Millward and
  • Elin Gray

23 November 2020

Immunotherapy is an important and established treatment option for patients with advanced melanoma. Initial anti-PD1 trials arbitrarily defined a two-year treatment duration, but a shorter treatment duration may be appropriate. In this study, we retr...

  • Article
  • Open Access
14 Citations
3,963 Views
16 Pages

Clinicopathological and Molecular Profiles of Sporadic Microsatellite Unstable Colorectal Cancer with or without the CpG Island Methylator Phenotype (CIMP)

  • Shih-Ching Chang,
  • Anna Fen-Yau Li,
  • Pei-Ching Lin,
  • Chun-Chi Lin,
  • Hung-Hsin Lin,
  • Shen-Chieh Huang,
  • Chien-Hsing Lin,
  • Wen-Yi Liang,
  • Wei-Shone Chen and
  • Jeng-Kai Jiang
  • + 3 authors

23 November 2020

Background: The 5’-C-phosphate-G-3’ island methylator phenotype (CIMP) is a specific phenotype of colorectal cancer (CRC) associated with microsatellite instability-high (MSI-high) tumors. Methods: In this study, we determined the CIMP st...

of 42

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Cancers - ISSN 2072-6694